It’s the weekend, and we hope you are finding a little rest, relaxation, and joy at home.
In today’s Special Weekend Edition of Good Day BIO, we’re taking a brief break from all the news surrounding COVID-19 to share the latest episode of the I AM BIO podcast: Sickle…
In this episode, you'll hear from three inspiring guests:
Global Blood Therapeutics CEO Dr. Ted Love, who talks about the history of the disease and how GBT’s diverse, majority-minority workforce drove this groundbreaking discovery.
Mapillar Dahn, Founder of the My Three Sicklers Sickle Cell Foundation, who has three daughters born with the disease. She talks about the realities of discrimination in U.S. health systems.
Dr. Helen Torley, CEO of Halozyme and the leader of BIO’s Workforce Development, Diversity and Inclusion Committee, who explains how BIO is working to create a new generation of diverse leadership in the biotech industry, and how the sickle cell breakthrough shows why it's important for biotech workforces to represent the communities they serve.
Why it matters: Whether it’s fighting Covid-19 or looking for innovative ways to treat other devastating diseases, providing hope and saving lives is what the men and women of the biopharmaceutical industry strive for every day.